Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adenocarcinoma
>>
AstraZeneca
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Recentin
(cediranib) / AstraZeneca
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
Imjudo
(tremelimumab) / AstraZeneca, Pfizer
Imfinzi
(durvalumab) / AstraZeneca
fexagratinib
(ABSK091) / Abbisko
saracatinib
(AZD0530) / AstraZeneca
Abegrin
(etaracizumab) / AstraZeneca
vistusertib
(AZD2014) / AstraZeneca
